Clinical trials in head injury - PubMed (original) (raw)
Review
doi: 10.1089/089771502753754037.
Mary Ellen Michel, Beth Ansell, Alex Baethmann, Anat Biegon, Michael B Bracken, M Ross Bullock, Sung C Choi, Guy L Clifton, Charles F Contant, William M Coplin, W Dalton Dietrich, Jamshid Ghajar, Sean M Grady, Robert G Grossman, Edward D Hall, William Heetderks, David A Hovda, Jack Jallo, Russell L Katz, Nachshon Knoller, Patrick M Kochanek, Andrew I Maas, Jeannine Majde, Donald W Marion, Anthony Marmarou, Lawrence F Marshall, Tracy K McIntosh, Emmy Miller, Noel Mohberg, J Paul Muizelaar, Lawrence H Pitts, Peter Quinn, Gad Riesenfeld, Claudia S Robertson, Kenneth I Strauss, Graham Teasdale, Nancy Temkin, Ronald Tuma, Charles Wade, Michael D Walker, Michael Weinrich, John Whyte, Jack Wilberger, A Byron Young, Lorraine Yurkewicz
Affiliations
- PMID: 12042091
- PMCID: PMC1462953
- DOI: 10.1089/089771502753754037
Review
Clinical trials in head injury
Raj K Narayan et al. J Neurotrauma. 2002 May.
Abstract
Traumatic brain injury (TBI) remains a major public health problem globally. In the United States the incidence of closed head injuries admitted to hospitals is conservatively estimated to be 200 per 100,000 population, and the incidence of penetrating head injury is estimated to be 12 per 100,000, the highest of any developed country in the world. This yields an approximate number of 500,000 new cases each year, a sizeable proportion of which demonstrate significant long-term disabilities. Unfortunately, there is a paucity of proven therapies for this disease. For a variety of reasons, clinical trials for this condition have been difficult to design and perform. Despite promising pre-clinical data, most of the trials that have been performed in recent years have failed to demonstrate any significant improvement in outcomes. The reasons for these failures have not always been apparent and any insights gained were not always shared. It was therefore feared that we were running the risk of repeating our mistakes. Recognizing the importance of TBI, the National Institute of Neurological Disorders and Stroke (NINDS) sponsored a workshop that brought together experts from clinical, research, and pharmaceutical backgrounds. This workshop proved to be very informative and yielded many insights into previous and future TBI trials. This paper is an attempt to summarize the key points made at the workshop. It is hoped that these lessons will enhance the planning and design of future efforts in this important field of research.
Figures
FIG. 1.
Glasgow Outcome Scale scores at 6 months postinjury in patients <46 years of age and admission temperature ≤35°C.
Similar articles
- Inflammation and neuroprotection in traumatic brain injury.
Corps KN, Roth TL, McGavern DB. Corps KN, et al. JAMA Neurol. 2015 Mar;72(3):355-62. doi: 10.1001/jamaneurol.2014.3558. JAMA Neurol. 2015. PMID: 25599342 Free PMC article. Review. - Cross-sectional analysis of data from the U.S. clinical trials database reveals poor translational clinical trial effort for traumatic brain injury, compared with stroke.
Li LM, Menon DK, Janowitz T. Li LM, et al. PLoS One. 2014 Jan 8;9(1):e84336. doi: 10.1371/journal.pone.0084336. eCollection 2014. PLoS One. 2014. PMID: 24416218 Free PMC article. - Combination therapies for traumatic brain injury: prospective considerations.
Margulies S, Hicks R; Combination Therapies for Traumatic Brain Injury Workshop Leaders. Margulies S, et al. J Neurotrauma. 2009 Jun;26(6):925-39. doi: 10.1089/neu.2008.0794. J Neurotrauma. 2009. PMID: 19331514 Free PMC article. - The future of Cochrane Neonatal.
Soll RF, Ovelman C, McGuire W. Soll RF, et al. Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834 - Design of acute neuroprotection studies.
Hawryluk GW, Bullock MR. Hawryluk GW, et al. Handb Clin Neurol. 2015;128:761-78. doi: 10.1016/B978-0-444-63521-1.00047-9. Handb Clin Neurol. 2015. PMID: 25701919 Review.
Cited by
- Practical pearls for management of cranial injury in the developing world.
Detchou D, Darko K, Barrie U. Detchou D, et al. Neurosurg Rev. 2024 Sep 10;47(1):579. doi: 10.1007/s10143-024-02822-1. Neurosurg Rev. 2024. PMID: 39251507 Review. - Human-Induced Pluripotent Stem Cell-Derived Neural Stem Cell Therapy Limits Tissue Damage and Promotes Tissue Regeneration and Functional Recovery in a Pediatric Piglet Traumatic-Brain-Injury Model.
Schantz SL, Sneed SE, Fagan MM, Golan ME, Cheek SR, Kinder HA, Duberstein KJ, Kaiser EE, West FD. Schantz SL, et al. Biomedicines. 2024 Jul 25;12(8):1663. doi: 10.3390/biomedicines12081663. Biomedicines. 2024. PMID: 39200128 Free PMC article. - Critical thresholds of long-pressure reactivity index and impact of intracranial pressure monitoring methods in traumatic brain injury.
Hong E, Froese L, Pontén E, Fletcher-Sandersjöö A, Tatter C, Hammarlund E, Åkerlund CAI, Tjerkaski J, Alpkvist P, Bartek J Jr, Raj R, Lindblad C, Nelson DW, Zeiler FA, Thelin EP. Hong E, et al. Crit Care. 2024 Jul 29;28(1):256. doi: 10.1186/s13054-024-05042-7. Crit Care. 2024. PMID: 39075480 Free PMC article. - Traumatic brain injury heterogeneity affects cell death and autophagy.
McDonald BZ, Tarudji AW, Zhang H, Ryu S, Eskridge KM, Kievit FM. McDonald BZ, et al. Exp Brain Res. 2024 Jul;242(7):1645-1658. doi: 10.1007/s00221-024-06856-1. Epub 2024 May 24. Exp Brain Res. 2024. PMID: 38789796 - Mitochondria-Targeted Antioxidant Therapeutics for Traumatic Brain Injury.
Modi HR, Musyaju S, Ratcliffe M, Shear DA, Scultetus AH, Pandya JD. Modi HR, et al. Antioxidants (Basel). 2024 Feb 29;13(3):303. doi: 10.3390/antiox13030303. Antioxidants (Basel). 2024. PMID: 38539837 Free PMC article. Review.
References
- BIEGON A, BAR JOSEPH A. Development of HU-211 as a neuroprotectant for ischemic brain damage. Neurol. Res. 1995;17:275–280. - PubMed
- BRAAKMAN R, SCHOUTEN HJ, BLAAUW-VAN DISHOECK M, et al. Megadose steroids in severe head injury. J. Neurosurg. 1983;58:326–330. - PubMed
- CHOI SC, MARMAROU A, BULLOCK R, et al. Primary endpoints in phase III clinical trials of severe head trauma: DRS versus GOS. J. Neurotrauma. 1998;15:771–776. - PubMed
- CHOI SC, BULLOCK R. Design and statistical issues in multicenter trials of severe head injury. Neurol. Res. 2001;23:190–192. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical